ID   M4K5_HUMAN              Reviewed;         846 AA.
AC   Q9Y4K4; Q8IYF6;
DT   30-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   15-FEB-2017, entry version 151.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase kinase 5;
DE            EC=2.7.11.1;
DE   AltName: Full=Kinase homologous to SPS1/STE20;
DE            Short=KHS;
DE   AltName: Full=MAPK/ERK kinase kinase kinase 5;
DE            Short=MEK kinase kinase 5;
DE            Short=MEKKK 5;
GN   Name=MAP4K5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAB48435.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF LYS-49.
RC   TISSUE=T-cell;
RX   PubMed=9038372; DOI=10.1038/sj.onc.1200877;
RA   Tung R.M., Blenis J.;
RT   "A novel human SPS1/STE20 homologue, KHS, activates jun N-terminal
RT   kinase.";
RL   Oncogene 14:653-659(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LYS-473.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000305}
RP   INTERACTION WITH CRK AND CRKL.
RX   PubMed=9788432; DOI=10.1038/sj.onc.1202108;
RA   Oehrl W., Kardinal C., Ruf S., Adermann K., Groffen J., Feng G.-S.,
RA   Blenis J., Tan T.-H., Feller S.M.;
RT   "The germinal center kinase (GCK)-related protein kinases HPK1 and KHS
RT   are candidates for highly selective signal transducers of Crk family
RT   adapter proteins.";
RL   Oncogene 17:1893-1901(1998).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-335, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [7]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-334; LEU-407; VAL-446; LYS-473;
RP   GLN-552 AND MET-633.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May play a role in the response to environmental stress.
CC       Appears to act upstream of the JUN N-terminal pathway.
CC       {ECO:0000269|PubMed:9038372}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:9038372}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:9038372};
CC   -!- SUBUNIT: Interacts with both SH3 domains of the adapter proteins
CC       CRK and CRKL. {ECO:0000269|PubMed:9788432}.
CC   -!- INTERACTION:
CC       P46108:CRK; NbExp=5; IntAct=EBI-1279, EBI-886;
CC       P62993:GRB2; NbExp=4; IntAct=EBI-1279, EBI-401755;
CC       P16333:NCK1; NbExp=2; IntAct=EBI-1279, EBI-389883;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9038372}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed in all tissues
CC       examined, with high levels in the ovary, testis and prostate.
CC       {ECO:0000269|PubMed:9038372}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U77129; AAB48435.1; -; mRNA.
DR   EMBL; BC036013; AAH36013.1; -; mRNA.
DR   RefSeq; NP_006566.2; NM_006575.4.
DR   RefSeq; NP_942089.1; NM_198794.2.
DR   RefSeq; XP_006720076.1; XM_006720013.3.
DR   UniGene; Hs.130491; -.
DR   ProteinModelPortal; Q9Y4K4; -.
DR   SMR; Q9Y4K4; -.
DR   BioGrid; 116353; 16.
DR   IntAct; Q9Y4K4; 9.
DR   MINT; MINT-7241969; -.
DR   STRING; 9606.ENSP00000013125; -.
DR   BindingDB; Q9Y4K4; -.
DR   ChEMBL; CHEMBL4852; -.
DR   GuidetoPHARMACOLOGY; 2089; -.
DR   iPTMnet; Q9Y4K4; -.
DR   PhosphoSitePlus; Q9Y4K4; -.
DR   BioMuta; MAP4K5; -.
DR   DMDM; 30316147; -.
DR   EPD; Q9Y4K4; -.
DR   MaxQB; Q9Y4K4; -.
DR   PaxDb; Q9Y4K4; -.
DR   PeptideAtlas; Q9Y4K4; -.
DR   PRIDE; Q9Y4K4; -.
DR   DNASU; 11183; -.
DR   GeneID; 11183; -.
DR   KEGG; hsa:11183; -.
DR   CTD; 11183; -.
DR   DisGeNET; 11183; -.
DR   GeneCards; MAP4K5; -.
DR   HGNC; HGNC:6867; MAP4K5.
DR   HPA; HPA036696; -.
DR   MIM; 604923; gene.
DR   neXtProt; NX_Q9Y4K4; -.
DR   PharmGKB; PA30613; -.
DR   eggNOG; KOG0576; Eukaryota.
DR   eggNOG; ENOG410XP9G; LUCA.
DR   HOGENOM; HOG000230824; -.
DR   HOVERGEN; HBG036702; -.
DR   InParanoid; Q9Y4K4; -.
DR   KO; K08833; -.
DR   PhylomeDB; Q9Y4K4; -.
DR   TreeFam; TF105121; -.
DR   SignaLink; Q9Y4K4; -.
DR   SIGNOR; Q9Y4K4; -.
DR   ChiTaRS; MAP4K5; human.
DR   GeneWiki; MAP4K5; -.
DR   GenomeRNAi; 11183; -.
DR   PRO; PR:Q9Y4K4; -.
DR   Proteomes; UP000005640; Unplaced.
DR   Bgee; ENSG00000012983; -.
DR   CleanEx; HS_MAP4K5; -.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0008349; F:MAP kinase kinase kinase kinase activity; IEA:InterPro.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004702; F:signal transducer, downstream of receptor, with serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0007257; P:activation of JUN kinase activity; TAS:ProtInc.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR001180; CNH_dom.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR021160; MAPKKKK.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   Pfam; PF00780; CNH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF038172; MAPKKKK; 1.
DR   SMART; SM00036; CNH; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50219; CNH; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Cytoplasm; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    846       Mitogen-activated protein kinase kinase
FT                                kinase kinase 5.
FT                                /FTId=PRO_0000086282.
FT   DOMAIN       20    277       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      506    819       CNH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00795}.
FT   NP_BIND      26     34       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    140    140       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   BINDING      49     49       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159,
FT                                ECO:0000269|PubMed:9038372}.
FT   MOD_RES     335    335       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     433    433       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BPM2}.
FT   VARIANT      41     41       H -> Y (in dbSNP:rs34726242).
FT                                /FTId=VAR_057102.
FT   VARIANT     334    334       A -> T (in dbSNP:rs12881869).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040747.
FT   VARIANT     407    407       P -> L (in dbSNP:rs34818002).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040748.
FT   VARIANT     446    446       I -> V (in dbSNP:rs55815015).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040749.
FT   VARIANT     473    473       N -> K (in dbSNP:rs35768475).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040750.
FT   VARIANT     552    552       R -> Q (in dbSNP:rs55997280).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040751.
FT   VARIANT     633    633       T -> M (in dbSNP:rs17780143).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040752.
FT   MUTAGEN      49     49       K->R: Loss of kinase activity and ability
FT                                to activate JNK family.
FT                                {ECO:0000269|PubMed:9038372}.
SQ   SEQUENCE   846 AA;  95040 MW;  B17F95196AA14E08 CRC64;
     MEAPLRPAAD ILRRNPQQDY ELVQRVGSGT YGDVYKARNV HTGELAAVKI IKLEPGDDFS
     LIQQEIFMVK ECKHCNIVAY FGSYLSREKL WICMEYCGGG SLQDIYHVTG PLSELQIAYV
     CRETLQGLAY LHTKGKMHRD IKGANILLTD HGDVKLADFG VAAKITATIA KRKSFIGTPY
     WMAPEVAAVE KNGGYNQLCD IWAVGITAIE LGELQPPMFD LHPMRALFLM SKSNFQPPKL
     KDKTKWSSTF HNFVKIALTK NPKKRPTAER LLTHTFVAQP GLSRALAVEL LDKVNNPDNH
     AHYTEADDDD FEPHAIIRHT IRSTNRNARA ERTASEINFD KLQFEPPLRK ETEARDEMGL
     SSDPNFMLQW NPFVDGANTG KSTSKRAIPP PLPPKPRISS YPEDNFPDEE KASTIKHCPD
     SESRAPQILR RQSSPSCGPV AETSSIGNGD GISKLMSENT EGSAQAPQLP RKNDKRDFPK
     PAINGLPPTP KVLMGACFSK VFDGCPLKIN CATSWIHPDT KDQYIIFGTE DGIYTLNLNE
     LHEATMEQLF PRKCTWLYVI NNTLMSLSEG KTFQLYSHNL IALFEHAKKP GLAAHIQTHR
     FPDRILPRKF ALTTKIPDTK GCHKCCIVRN PYTGHKYLCG ALQSGIVLLQ WYEPMQKFML
     IKHFDFPLPS PLNVFEMLVI PEQEYPMVCV AISKGTESNQ VVQFETINLN SASSWFTEIG
     AGSQQLDSIH VTQLERDTVL VCLDKFVKIV NLQGKLKSSK KLASELSFDF RIESVVCLQD
     SVLAFWKHGM QGKSFKSDEV TQEISDETRV FRLLGSDRVV VLESRPTENP TAHSNLYILA
     GHENSY
//
